medline.ch Onkologie Gynäkologische Tumoren

	Post-operative acute pain assessment and management in breast cancer patients: a best practice implementation project. JBI Evid Implement Zhong X, Tang H, Wu C, Zhang L, Chen W, Li Q, Ou Q, Xu H. PMID: 42184243 [PubMed - as supplied by publisher]
	An Adaptive Fusion Network for Breast Tumor Grading Based on Graph Structure Learning. IEEE J Biomed Health Inform Yang L, Li K, Yu Z, Jiang Y, Han S, Zhao X, Gao J, Jiang H, Ma L. PMID: 42184189 [PubMed - as supplied by publisher]
	Datopotamab deruxtecan for endocrine-resistant HR-positive/HER2-negative breast cancer: biological rationale and clinical evidence. Naunyn Schmiedebergs Arch Pharmacol Gumma B, Gumma L. PMID: 42183859 [PubMed - as supplied by publisher]
	Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy. J Radiat Res Sarsitthithum T, Nantavithya C, Lertbutsayanukul C, Saksornchai K. PMID: 42183732 [PubMed - as supplied by publisher]
	Breast Cancer Burden in BRICS Countries Attributable to Smoking, High Alcohol Use, High Body Mass Index, and Low Physical Activity, 1990-2021: Findings from the Global Burden of Disease 2021 and Mendelian Randomization. Int J Womens Health Yan X, Liao C, Qian S, Zhang C, Wu J, Fang J, Zhao X, Peng L. PMID: 42183404 [PubMed]
	Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical management. Front Immunol Shao M, Wang T, Ji L, Xu L, Zhang Y, Wang D, Jia C, Chen L, Zhang H, Yan W, Cui X, Tong R. PMID: 42183263 [PubMed - indexed for MEDLINE]
	Development and validation of a TLS-associated signature for prognosis prediction in breast cancer: new insights into QPRT. Front Immunol Li Q, Yang X, Wei L, Wang X, Wang X, Chen J, Zhao L, Wen S. PMID: 42183191 [PubMed - indexed for MEDLINE]
	Evaluation and Treatment Options for Abnormal Uterine Bleeding in Premenopausal Patients With a History of Breast Cancer. O G Open Nelis M, Chichura A. PMID: 42183172 [PubMed]
	Recent advances in the delivery of natural-product antioxidants for the treatment of breast cancer. Front Bioeng Biotechnol Almansoori FE, Lee S. PMID: 42183061 [PubMed]
	Targeting non-coding RNAs in the ferroptosis system: Molecular mechanisms and clinical translation for reversing doxorubicin resistance in breast cancer. Noncoding RNA Res Yu X, Xu A, Yao L, Huang X, Wang J, Fu D. PMID: 42183022 [PubMed]
	Evaluating an educational supportive care program on functional status and quality of life among women with breast cancer post-mastectomy in Egypt. Palliat Care Soc Pract Ali FK, Aljarrah I, Haddad RH, Abd El-Hamid SM, Abuejheisheh AJ. PMID: 42182050 [PubMed]
	Port-site metastases after diagnostic laparoscopy in advanced ovarian cancer: a case report and a systematic review of the literature. Front Surg De Tommasi O, Bigardi S, Incognito GG, Modena L, Goretti C, Spagnol G, Ettore C, Ettore G, Noventa M, Saccardi C, Tozzi R. PMID: 42181547 [PubMed]
	Ki-67 Quantification in Breast Cancer: A Comparison of Hotspot and Global Scoring Methods Using a Standardized Android Application. Cureus Patel M, Jawalkar S. PMID: 42181363 [PubMed]
	Research progress on precision targeted therapy strategies for breast cancer based on tumor microenvironment. iScience Luo Y, Xie P, Yang S, Qu P, Hou L, Yi Q. PMID: 42181279 [PubMed]
	Technical implementation for african pharmacogenetic studies on CYP2D6 from archived breast cancer formalin fixed paraffin-embedded (FFPE) tissues. MethodsX Nthontho KC, Tawe L, Mugo N, Mabaka R, Contino G, Ndlovu AK, Morse DP, Paganotti GM. PMID: 42181075 [PubMed]
	Nomogram prediction for breast cancer-specific survival in patients with ER(-)/PR(-)/HER2(+) breast cancer: an analysis based on the SEER population. Transl Cancer Res You L, Ge Y, Yong J, Li Y, Zhang L, Hu Q. PMID: 42180978 [PubMed]
	Development and validation of a macrophage-related prognostic model for overall survival in ovarian cancer via integrated RNA sequencing analysis. Transl Cancer Res Yu T, Yang G, Ren D, Li Y, Yue C, Yang Q, Zhang J. PMID: 42180968 [PubMed]
	Magnetic resonance imaging-based radiomics analysis: predicting vascular invasion in breast invasive ductal carcinoma using different machine learning models. Transl Cancer Res Li H, Zhang L, Zeng Y, Zhang Y, Ye Z. PMID: 42180954 [PubMed]
	CLIP2 is a potential biomarker for platinum resistance and prognosis in ovarian cancer: a bioinformatics analysis. Transl Cancer Res Qiu M, Zhao M, Zhao J, Zhao H, Jiang W, Yang L, Yang L. PMID: 42180947 [PubMed]
	Results of the feasibility study of clinical trials of the new cancer treatment technology Karanahan for patients with advanced breast cancer. Transl Cancer Res Proskurina AS, Markina VA, Ruzanova VS, Ritter GS, Dolgova EV, Kirikovich SS, Levites EV, Efremov YR, Vereschagin EI, Leplina OY, Ostanin AA, Chernykh ER, Kolchanov NA, Sidorov SV, Bogachev SS. PMID: 42180943 [PubMed]

Artikel 1 - 20 / 329169

Seite 1 von 16459

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung